Compare INO to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 1.18 |
|---|---|
| Trade Time: | Feb 9 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 1.18 |
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 4.00 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 0.18 - 3.40 |
| Volume: | 0 |
| Avg Vol (3m): | 670,397 |
| Market Cap: | 120.51M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.34 |
| Div & Yield: | N/A (N/A) |
| Mon, Feb 8 | Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical TrialBusiness Wire |
| Thu, Feb 4 | Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4Indie Research |
| Wed, Feb 3 | Inovio Biomedical to Present at BIO CEO & Investor ConferenceBusiness Wire |
| Wed, Jan 27 | Inovio Unveils Skin Electroporation Technology for Delivering DNA VaccinesBusiness Wire |
| Tue, Jan 19 | Inovio Biomedical to Present at Partnering and Vaccine ConferencesBusiness Wire |
| Mon, Jan 11 | Inovio Expands DNA Vaccine Intellectual Property License with University of PennsylvaniaBusiness Wire |
| Thu, Jan 7 | VGX Animal Health's Growth Hormone Releasing Hormone Shows Advantages Compared to Current Growth Hormone Therapies Used in PigsBusiness Wire |
| Thu, Jan 7 | Inovio Biomedical to Present at OneMedForum Investor ConferenceBusiness Wire |
| Tue, Jan 5 | Inovio Appoints Dr. Mark Bagarazzi as Chief Medical OfficerBusiness Wire |
| Tue, Dec 29 | Swine Flu Vaccine News Back From the DeadIndie Research |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.